https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

The IDIVAL organizes the first edition of the scientific dissemination course MEDCOM communicate your science

9 de September de 2019

The objective of the course is to improve the communication skills of our researchers in order to improve the performance of the dissemination and dissemination of scientific knowledge in our society, increasing the technological dimension of their culture. The course is open to researchers, clinical staff, students and the general public. The course is developed […]

Read more →

The Minister of Health signs the application to renew the IDIVAL accreditation as a Health Research Institute

The Minister of Health of the Government of Cantabria, Miguel Rodríguez, has visited the facilities of the Marqués de Valdecilla Research Institute (IDIVAL) to meet the research teams and the projects that are being carried out. During his visit, he was accompanied by the director of the center, Galo Peralta; the director of Public Health, […]

Read more →

IDIVAL researchers study surgical ergonomics in nasosinus endoscopic procedures

5 de September de 2019

The incidence of cervicobrachial disorders in otolaryngologists is high. In other surgical specialties, knowledge of this problem has prompted the creation of new equipment, improvements in the design and distribution of the operating room, as well as greater postural awareness. Given the strong physical and psychological demands of endoscopic sinus surgery (CENS) and the limited […]

Read more →

IDIVAL patents a multivalent vaccine against listeriosis tuberculosis and pneumonia

2 de September de 2019

After the last outbreak of listeriosis occurred in Spain, the bacterium Listeria monocytogenes, has established itself in Spain as one of the pathogens causing more virulent food infections. In general, immunocompromised individuals are those with a high risk of listeriosis, either due to natural immunosuppression such as pregnancy, newborns or the elderly, or due to […]

Read more →

IV Program of Conferences Santander Biomedical Lectures

26 de August de 2019

Following the success achieved in the past programs of Santander Biomedical Lectures, IDIVAL introduces the fourth program of conferences. World’s prestigious and recognized researchers for their international contributions.  For a consecutive year, the Cantabria Research Forum, made up of the Cantabrian Health Service together with the Valdecilla Research Institute (IDIVAL), the University of Cantabria (UC) […]

Read more →

Study the use of beta-lactam monotherapy in bacteremia caused by Pseudomonas aeruginosa

13 de August de 2019

IDIVAL researchers belonging to the group of Epidemiology and Pathogenic and Molecular Mechanisms of Infectious Diseases and Microbiology led by Dr. Carmen Fariñas, head of the Infectious Service of the Marqués de Valdecilla Hospital have participated in a study recently published in the journal Clinical Infectious Diseases. This is a multinational and multicenter study in […]

Read more →

Progress in the treatment of bladder cancer

12 de August de 2019

Cancer represents a major health problem. It is estimated that, in 2019, almost 280,000 people will be diagnosed with this disease in our country. These figures are higher than in previous years. The most common tumors in Spain are those of the colon, prostate, breast, lung and urinary bladder. As the number of new diagnoses […]

Read more →

Course of Standards of Good Clinical Practice IDIVAL

8 de August de 2019

The Marqués de Valdecilla Research Institute (IDIVAL) organizes from September 9th to 13th a course of Standards of Good Clinical Practice aimed at all those personnel of the biosanitary environment of Cantabria that have an interest in clinical research. This training activity it is intended to give these professionals the necessary tools for their participation […]

Read more →

Two new cases of lymphoma B lymphoplasmacytic IgA with mutation of MYD88L265P

7 de August de 2019

Recently, the description of two cases of IgA lymphoplasmacytic lymphoma B with MYD88L265P mutation has been published in the journal HISTOPATHOLOGY (FI 3,294, JCR). In this work, in which medical researchers from the IDIVAL Emerging Group of Translational Hematopathology and doctors from the Pathology and Hematology Department of the HUMV have participated, two extremely unusual […]

Read more →

Decreased levels of TNF-alpha in women treated with CPAP

6 de August de 2019

Researchers of the SPANISH SLEEP GROUP belonging to IDIVAL and who carry out their clinical and research activity in the Sleep and Ventilation Unit of our hospital have just published a new paper belonging to the cohort of the SAHS study and women. This multicenter study, which has been funded by the Carlos III Health […]

Read more →